Interferons in Colorectal Cancer Pathogenesis and Therapy
Journal Title: Diseases & Research - Year 2024, Vol 4, Issue 1
Abstract
As key modulators of the immune response, interferons play critical roles following infection and during the pathogenesis of cancer. The idea that these cytokines might be developed as new therapies emerged soon after their discovery. While enthusiasm for this approach to cancer therapy has waxed and waned over the ensuing decades, recent advances in cancer immunotherapy and our improved understanding of the tumor immune environment have led to a resurgence of interest in this unique class of biologic drug. Here, we review how interferons influence the growth of colorectal cancers (CRCs) and highlight new insights into how interferons and drugs that modulate interferon expression might be most effectively deployed in the clinic
Authors and Affiliations
Lucy Petrova, Fred Bunz
Keywords
Related Articles
- EP ID EP740226
- DOI 10.54457/DR.202401005
- Views 28
- Downloads 1
Primary Extramedullary Plasmacytoma of the Kidney: A Case Report and Literature Review
Extramedullary plasmacytomas (EMPs) usually occur in the upper respiratory tract, the occurrence in the kidney is extremely rare. The present study reported a case of primary renal plasmacytoma in a 46-year-old male pati...
Interferons in Colorectal Cancer Pathogenesis and Therapy
As key modulators of the immune response, interferons play critical roles following infection and during the pathogenesis of cancer. The idea that these cytokines might be developed as new therapies emerged soon after th...
Role of Various Immune Cells in the Tumor Microenvironment
The tumor microenvironment (TME) has numerous promotive and suppressive effects on tumor growth. The TME harbors adaptive and innate immune cells such as T cells, B cells, natural killer (NK) cells, macrophages, neutroph...
Gut Microbiota is A Crucial Bridge Mediating the Pharmacological Effect of Labiatae Traditional Chinese Medicine
Labiatae, a family of the dicotyledonous plants, has attracted extensive interest because of its wide application in foods, drugs and cosmetics. According to the National Census of Chinese Medicine Resources, Labiatae co...
Recurrent Middle Ear Cancer: Case Report
Background: Middle ear cancer is clinically uncommon, representing approximately 1.5% of ear malignancies and 0.03% to 0.06% of all cancers. Recurrent cases of middle ear cancer are particularly rare. This report discuss...